tm logo

Monitor this mark

View On USPTO

CLENE NANOMEDICINE
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 02 May 2022

Last Applicant/ Owned by

CLENE NANOMEDICINE, INC.

6550 South Millrock Drive

Salt Lake City

UT

84121

Serial Number

86302980 filed on 06th Jun 2014

Registration Number

4864007 registered on 01st Dec 2015

in the Principal Register

Correspondent Address

Janet G Ricciuti

Janet G Ricciuti JANET GILBERT RICCIUTI, PC

WASHINGTON, DC 20009-6244

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

CLENE NANOMEDICINE

Pharmaceuticals for use in prevention and treatment of demyelinating diseases, autoimmune diseases, infectious diseases and cancer

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceuticals for use in prevention and treatment of demyelinating diseases, autoimmune diseases, infectious diseases and cancer

First Use Date in General

08th Sep 2015

First Use Date in Commerce

08th Sep 2015

Mark Details

Serial Number

No 86302980

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
01st Dec 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02th May 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02th May 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
27th Apr 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08th Nov 2021TEAS SECTION 8 & 15 RECEIVED
01st Dec 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01st Dec 2015REGISTERED-PRINCIPAL REGISTER
24th Oct 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
23rd Oct 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
24th Sep 2015STATEMENT OF USE PROCESSING COMPLETE